Funding for this research was provided by:
ANR “Programme d’Investissements d’Avenir” ((ANR-11-INBS-0009-INGESTEM))
Received: 9 June 2021
Accepted: 8 July 2021
First Online: 22 July 2021
: This manuscript contains transcriptomic data from samples with ethics considerations from the original publication: Adelman ER, Huang HT, Roisman A, and Olsson A et al. Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia. Cancer Discov 2019 Aug;9(8):1080-1101. DOI: 10.1158/2159-8290.CD-18-1474. All aged (65–75 years old) samples were derived from femurs from individuals undergoing hip replacement surgery at the University of Michigan Medical School or the University of Miami Miller School of Medicine. The study was approved by the Institutional Review Boards of the University of Michigan Medical School and University of Miami Miller School of Medicine. All material included in this study was de-identified, leftover material to be discarded after pathological review of the hip specimens, and was therefore exempt from human subjects research regulations. Donors had no known history of hematological malignancy.
: Not applicable.
: The authors declare that they have no competing interests.